Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC (AZN.L) is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday. The data indicates that th…